Physician profile
Daniel Chen
NPI 1356355812
$30,155.00
in general payments reported to CMS, 2019-2025
78 companies · $4,002 in 2025
The $4,002 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,777 · 2020: $2,340 · 2021: $3,872 · 2022: $3,811 · 2023: $5,113 · 2024: $3,242 · 2025: $4,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $1,120 · Education: $96.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,139.46 |
| Consulting Fee | $1,120.00 |
| Education | $96.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $6,717.11 | 2019-2025 | |
| Abbvie INC. | $2,510.25 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals Lp | $2,442.67 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $2,236.21 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,700.44 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $1,554.80 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $1,278.40 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $1,222.48 | 2019-2024 | Xarelto, Spravato |
| Amgen INC. | $1,207.21 | 2019-2025 | Repatha, Evenity, Prolia |
| Merck Sharp & Dohme LLC | $682.15 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Novartis Pharmaceuticals Corporation | $519.18 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $441.52 | 2019-2025 | Xifaxan |
| Allergan, INC. | $426.93 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $413.87 | 2019-2025 | Eliquis |
| Corcept Therapeutics | $389.09 | 2022-2025 | Korlym |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $381.66 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $373.95 | 2024-2025 | Voquezna |
| Xeris Pharmaceuticals, INC. | $330.44 | 2022-2025 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $263.76 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $238.66 | 2019-2023 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $230.86 | 2022 | |
| Astellas Pharma US INC | $226.72 | 2020-2024 | Veozah |
| Recordati_rare_diseases_inc. | $211.12 | 2025 | Isturisa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $206.76 | 2024-2025 | Caplyta |
| Dexcom, INC. | $204.97 | 2019-2024 | Dexcom G6 Transmitter |
| Radius Health, INC. | $203.54 | 2019-2025 | Tymlos |
| Kowa Pharmaceuticals America, INC. | $194.58 | 2019-2025 | Zoryve, Seglentis, Livalo |
| Takeda Pharmaceuticals U.S.A., INC. | $176.68 | 2019-2025 | Trintellix |
| Arbor Pharmaceuticals, INC. | $169.10 | 2019-2022 | |
| Indivior INC. | $159.38 | 2021-2025 | Sublocade |
| Teva Pharmaceuticals USA, INC. | $158.66 | 2020-2023 | Airduo Digihaler |
| Esperion Therapeutics, INC. | $151.78 | 2021-2025 | Nexletol |
| Sanofi Pasteur INC. | $144.39 | 2019-2025 | |
| Uswm, LLC | $139.68 | 2021-2023 | Zimhi, Lucemyra |
| Otsuka America Pharmaceutical, INC. | $125.32 | 2024-2025 | Rexulti |
| Braeburn INC. | $122.75 | 2024-2025 | Brixadi |
| Supernus Pharmaceuticals, INC. | $120.79 | 2019-2022 | |
| Eisai INC. | $120.01 | 2019-2021 | |
| Orexo US, INC. | $117.65 | 2019-2025 | Zubsolv |
| Biohaven Pharmaceuticals, INC. | $110.83 | 2021 | |
| Abbott Laboratories | $108.30 | 2022-2025 | Freestyle Libre 3 |
| Centinel Spine, LLC | $104.17 | 2023 | Prodisc L |
| Sumitomo Pharma America, INC. | $100.26 | 2023-2025 | Gemtesa |
| Exact Sciences Corporation | $90.41 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Horizon Therapeutics Plc | $84.63 | 2020-2021 | |
| Genzyme Corporation | $82.83 | 2023 | |
| Ardelyx, INC. | $82.34 | 2024 | Ibsrela |
| Redhill Biopharma INC. | $82.03 | 2020 | |
| Hologic Sales and Service, LLC | $69.76 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Almatica Pharma LLC | $55.61 | 2023-2024 | Loreev Xr |
| Idorsia Pharmaceuticals US INC | $43.83 | 2022-2025 | Quviviq |
| Kyowa Kirin, INC. | $43.39 | 2024-2025 | Crysvita |
| Bausch Health US, LLC | $41.16 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $40.29 | 2023 | Edarbi |
| Seqirus USA INC | $39.40 | 2022-2024 | Flucelvax |
| Vivus LLC | $33.36 | 2019 | |
| Genentech USA, INC. | $30.93 | 2019-2020 | |
| Cranial Technologies, INC | $30.62 | 2019-2024 | Doc Band |
| Inspire Medical Systems, INC. | $28.12 | 2024 | Inspire |
| Axsome Therapeutics, INC. | $25.32 | 2023 | Auvelity |
| Amneal Pharmaceuticals LLC | $25.13 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $24.39 | 2023 | Strensiq |
| Ultragenyx Pharmaceutical INC. | $22.31 | 2022 | |
| Avanir Pharmaceuticals, INC. | $22.18 | 2022 | |
| Edwards Lifesciences Corporation | $20.20 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $19.22 | 2021 | |
| Ibsa Pharma INC. | $17.52 | 2021 | |
| Pear Therapeutics (US), INC. | $17.27 | 2022 | |
| Boston Scientific Corporation | $16.25 | 2019 | |
| Phadia US INC. | $15.96 | 2024 | Immunocap |
| Integra Lifesciences Corporation | $15.64 | 2021 | |
| Kaleo, INC. | $15.18 | 2019 | |
| Medtronic Minimed, INC. | $14.91 | 2020 | |
| Ironwood Pharmaceuticals, INC | $14.28 | 2019 | |
| Theracosbio, LLC | $14.26 | 2024 | Brenzavvy |
| Assertio Therapeutics, INC. | $13.11 | 2019 | |
| Mdd US Operations, LLC | $12.14 | 2019 | |
| Avion Pharmaceuticals | $11.94 | 2020 |
Drugs and devices associated with these payments
Jardiance $946Vraylar $753Nurtec Odt $716Airsupra $575Ozempic $537Farxiga $515Synjardy $418Zavzpret $383Voquezna $374Tradjenta $372Eliquis $368Mounjaro $367Trelegy Ellipta $350Korlym $317Zepbound $286Gvoke Hypopen $284Rybelsus $280Ubrelvy $265Repatha $257Shingrix $248Isturisa $211Qulipta $209Caplyta $207Arexvy $201Evenity $187Gardasil 9 $161Kerendia $154Veozah $144Xarelto $143Dexcom G6 Transmitter $128Rexulti $125Otezla $124Brixadi $123Spravato $117Tymlos $116Sublocade $116Paxlovid $114Vaxneuvance $112Prodisc L $104Wegovy $104Gemtesa $100Prolia $98.22Dalvance $97.02Leqvio $96.83Vaxelis $96.28Xifaxan $91.75Breztri $91.40Trintellix $86.46Zubsolv $85.43Dupixent $82.83Ibsrela $82.34Capvaxive $80.01M-M-R II $78.33Aptima $69.76Freestyle Libre 3 $64.36Glyxambi $63.80Lucemyra $59.56Zimhi $59.56Verquvo $58.66Fluzone High-Dose $58.32Loreev Xr $55.61Gardasil $51.75Botox $48.85The Cologuard Plus Collection Kit $45.85Nexletol $45.02Cologuard Collection Kit $44.56Flublok Quadrivalent Northern Hemisphere $43.88Crysvita $43.39Emgality $40.85Entresto $40.82Edarbi $40.29Krystexxa $34.47Teflaro $33.51Beyfortus $30.80Zoryve $29.70Belsomra $29.33Steglatro $29.33Inspire $28.12Fluzone Quadrivalent Northern Hemisphere $27.52Comirnaty $25.71Prevnar 20 $25.71Abrysvo $25.71Auvelity $25.32Strensiq $24.39Flumist Quadrivalent $23.55Flucelvax $21.59Quviviq $21.17Soliqua 100/33 $21.03Edwards Sapien 3 Transcatheter Heart Valve (Thv) $20.20Lokelma $19.80Thinprep 2000 Processor $19.10Linzess $18.64Creon $18.64Airduo Digihaler $16.49Immunocap $15.96Doc Band $15.54Brenzavvy $14.26Proquad $13.87Steglujan $13.12Seglentis $13.10
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.